期刊论文详细信息
Clinical Epigenetics 卷:18
The role of epigenetic age acceleration and social disadvantage in cardiometabolic health in southeast Louisiana women
Research
Alicia K. Smith1,2,3  Seyma Katrinli1,2  Julian L. Moran4  Kristyne D. Mansilla Dubon5  Sierra N. Garth5  Michael Simmond1  Dawayland O. Cobb1  Meghan Brashear5  Edward J. Trapido6  Erika J. Wolf7  Ariane L. Rung5  Nicole R. Nugent8,9,10  Edward S. Peters5 
[1] Department of Emergency Medicine, Alpert Brown Medical School, Providence, USA
[2] Epidemiology Program, Louisiana State University School of Public Health, New Orleans, USA
[3] Department of Psychiatry, National Center for PTSD at VA Boston Healthcare System, Boston University Chobanian & Avedisian School of Medicine, Boston, USA
[4] Department of Gynecology and Obstetrics, School of Medicine, Emory University, Atlanta, USA
[5] School of Medicine, Emory University, Atlanta, USA
[6] Department of Psychiatry & Behavioral Sciences, School of Medicine, Emory University, Atlanta, USA
[7] Department of Human Genetics, School of Medicine, Emory University, Atlanta, USA
[8] Department of Psychiatry and Human Behavior, Alpert Brown Medical School, Providence, USA
[9] Epidemiology Department, University of Nebraska Medical Center College of Public Health, Omaha, USA
[10] Department of Pediatrics, Alpert Medical School of Brown University Box G-BH, 02912, Providence, RI, USA
关键词: Epigenetic age acceleration;    DNA methylation;    Cardiometabolic disease;    Cardiovascular disease;    Diabetes;    Social disadvantage;    Socioeconomic status;    Area Deprivation Index;    Women’s health;   
DOI  :  10.1186/s13148-026-02183-0
 received in 2026-02-24, accepted in 2026-06-15,  发布年份 2026
来源: Springer
【 摘 要 】

BackgroundCardiometabolic risk factors can disrupt DNA methylation (DNAm) patterns, accelerate cellular aging, and contribute to age-related disorders, including cardiovascular disease (CVD) and diabetes. Social disadvantage may exacerbate these biological processes, yet its relationship with epigenetic aging and cardiometabolic disease across time remains incompletely understood. We examined associations between epigenetic age acceleration and both social disadvantage and cardiometabolic diseases. We assessed whether these associations differed in each study wave.ResultsParticipants were drawn from The Women and Their Children’s Health (WaTCH) cohort and assessed at Wave 1 (2012–2014; N = 865) and Wave 3 (2023–2025; N = 348). At Wave 1, participants had a mean age of 46.9 ± 11.9 years and identified as Black (38.0%) or White (56.2%). Social disadvantage was assessed using an individual-level socioeconomic status (SES) index (education, income, and health insurance) and the Area Deprivation Index (ADI). DNAm was measured from blood samples to derive epigenetic age acceleration metrics (GrimAge2, PhenoAge, and DunedinPACE). Lower SES index and higher ADI were associated with greater epigenetic age acceleration and a faster pace of aging. CVD (45.2%) and diabetes (15.6%) at Wave 1 were more prevalent among participants with lower SES index, higher ADI, Black race, and higher body mass index (BMI). After adjustment for BMI, alcohol use, ADI, SES, smoking, and cell composition, both CVD and diabetes were associated with higher GrimAge2 and PhenoAge acceleration and a faster pace of aging at Wave 1. At Wave 3, diabetes was associated with all measures of epigenetic age acceleration after covariate adjustment.ConclusionsCVD and diabetes were more common among socially disadvantaged women and were associated with accelerated epigenetic aging. These findings highlight the biological correlates of social disadvantage and underscore the need for targeted public health interventions addressing social drivers of health to mitigate cardiometabolic disease risk.

【 授权许可】

CC BY   
© The Author(s) 2026

附件列表
Files Size Format View
Table 1 6KB Table download
Supporting File 2 2601KB Other download
Supporting File 6 17158KB Other download
TABLE 3 1KB Table download
【 参考文献 】
  • [1]
  • [2]
  • [3]
  • [4]
  • [5]
  • [6]
  • [7]
  • [8]
  • [9]
  • [10]
  • [11]
  • [12]
  • [13]
  • [14]
  • [15]
  • [16]
  • [17]
  • [18]
  • [19]
  • [20]
  • [21]
  • [22]
  • [23]
  • [24]
  • [25]
  • [26]
  • [27]
  • [28]
  • [29]
  • [30]
  • [31]
  • [32]
  • [33]
  • [34]
  • [35]
  • [36]
  • [37]
  • [38]
  • [39]
  • [40]
  • [41]
  • [42]
  • [43]
  • [44]
  • [45]
  • [46]
  • [47]
  • [48]
  • [49]
  • [50]
  • [51]
  • [52]
  • [53]
  文献评价指标  
  下载次数:0次 浏览次数:0次